| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,447 | 1,440 | 1,588 | 2,316 | | Cost of Revenue | 450 | 797 | 1,070 | 1,332 | | | Gross Profit | 997 | 644 | 518 | 984 | | | Operating Expenses | | Research Development | 113 | 239 | 143 | 74 | | Selling General and Administrative | 1,138 | 1,203 | 968 | 1,289 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 109 | 1,456 | 114 | 87 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (364) | (2,255) | (707) | (467) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,164) | (1,678) | 898 | (1,084) | | Earnings Before Interest And Taxes | (2,528) | (3,970) | 256 | (1,524) | | Interest Expense | 592 | 518 | 495 | 430 | | Income Before Tax | (3,120) | (4,489) | (239) | (1,954) | | Income Tax Expense | (809) | (3,380) | (0) | 19 | | Minority Interest | 16 | (37) | 66 | 27 | | | | Net Income From Continuing Ops | (2,295) | (1,109) | (239) | (1,973) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,295) | (1,109) | (239) | (1,973) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,295) | ($1,109) | ($239) | ($1,973) |
|
0.51% Nasdaq 
Income Statement
